Intersections Appoints Johan Roets as Next CEO

Intersections Appoints Johan Roets as Next CEO

Intersections, a provider of identity risk management and privacy protection services for consumers, appointed Johan Roetsas chief executive officer effective Jan. 10. Michael Stanfield will assume the role of chairman and founder and will continue to serve as the chairman of the board. Roets joined Intersections in September 2014, as chief operating officer and quickly added president, Identity Guard to his role.

Read More ˃
Vanda Sees Q4 Revenues Below Street Estimate

Vanda Sees Q4 Revenues Below Street Estimate

Vanda Pharmaceuticals said Monday that it expects to report total net product sales from Hetlioz and Fanapt of approximately $38 million for Q4, and approximately $146 million for full year 2016. The Street estimates call for total revenues of $39.7 million and $147.5 million for Q4 and 2016, respetively. For 2017, the company expects net product sales from Hetlioz and fanapt of between $165 million and $175 million. Cash is […]

Read More ˃
Alamos Gold Hits 2016 Production Target

Alamos Gold Hits 2016 Production Target

Alamos Gold Friday said production for 2016 was in line with its guidance, with record quarterly results in Q4, and provided its output and capital program targets for 2017. The company produced 392,000 ounces of gold in 2016, above the mid-point of guidance and ahead of last year’s 380,000 ounces. For Q4, production was 105,676 ounces versus 104,734 ounces for the year-earlier quarter. For 2017, gold production is expected to […]

Read More ˃
Interface to Close Most FLOR Stores in Restructuring Plan

Interface to Close Most FLOR Stores in Restructuring Plan

Interface will close the majority of its FLOR retail stores between January and April and take a charge of a total of about $25 to $27 million in a restructuring plan. The job reductions include about 70 FLOR workers and “a number of other employees in the commercial business in the Americas and Europe regions,” the company said. In Q4 2016, the company expects to incur a pre-tax restructuring and […]

Read More ˃
Arthur J. Gallagher & Co Touches Record High

Arthur J. Gallagher & Co Touches Record High

Arthur J. Gallagher & Co said Wednesday it acquired Gruppo Marcucci, without disclosing the terms of the deal. Shares of Gallagher climbed more than 1% intraday, touching their highest level ever. Founded in 2005, Gruppo Marcucci is a Chicago-based consulting firm specializing in human resources and benefits technology solutions, according to a company statement. Led by partners Rhonda Marcucci and Ed Barry, the Gruppo Marcucci team will continue to operate […]

Read More ˃
Teligent Shares Gain 3.6%

Teligent Shares Gain 3.6%

Teligent, a New Jersey-based specialty generic pharmaceutical company, said Wednesday it got approvals for three of its abbreviated new drug applications (ANDAs) from the U.S. Food and Drug Administration (FDA). Shares climbed 3.6% intraday. The permission was granted for Nystatin and Triamcinolone Acetonide ointment USP, 100,000 units/gram and 1 mg/gram, Clindamycin Phosphate topical solution USP, 1% and Flurandrenolide ointment USP, 0.05%, according to a statement. The approvals were received Dec. […]

Read More ˃